CMS Just Paused Medicare Payments for 447 California Hospices. Here’s What the Qlarant Letter Means and the 15-Day Clock You’re On.

In mid-April 2026, a White House–led federal anti-fraud task force quietly triggered one of the largest enforcement actions in the history of the Medicare hospice benefit. Roughly 447 California hospices and 23 home health agencies — most concentrated in Los Angeles County — received “Notice of Suspension of Medicare Payments” letters from Qlarant Integrity Solutions, LLC. For many, payments had already been frozen before the letter ever arrived.

If you got one of these letters, this post is what you need to read first. If you didn’t, keep reading anyway — the methodology CMS used to pick the 447 is the same methodology they’re going to apply to every hospice in PPEO states going forward.

What the Letter Actually Says

The letters are signed by Kristi Arias, Manager of Program Integrity at the Western Jurisdiction Unified Program Integrity Contractor (UPICW) — Qlarant. The essential structure of every letter is the same:

• Statutory authority: 42 C.F.R. § 405.371(a)(2) and § 405.372(a)(4)(iii)
• Basis: A “credible allegation of fraud” consulted with HHS-OIG
• Effect: Full suspension of Medicare payments, effective before the letter was sent
• Rationale for no prior notice: Advance notice “would have placed additional Medicare funds at risk and hindered CMS’ ability to recover any determined overpayment”
• Primary allegation in most letters: An elevated live discharge rate — the audit window appears to cover any rate over roughly 40%, with letters seen so far cited at rates anywhere from the mid-50% range up to 100%, all materially higher than national hospice patterns (~17–18%)
• Rebuttal window: 15 business days from receipt under 42 C.F.R. § 405.372(b)

The letter is not an audit request. It is not a denial. It is not a revocation. It is a suspension — meaning claims continue to be processed but no money is released while the investigation runs. Funds accumulate in a suspense account that can later be applied to any determined overpayment before anything is returned to the provider.

The Scale: Why 447 at Once

The April 2026 sweep is not a coincidence of timing. It is the operational output of a federal task force created by executive order in March 2026 and led by Vice President J.D. Vance. The task force combines personnel from the Department of Justice, HHS (including OIG and CMS), Homeland Security, and Labor. Its distinguishing feature is scale: it uses AI-assisted billing data review to flag providers en masse rather than one at a time.

The numbers reported publicly:

• 447 hospices + 23 home health agencies suspended
• Approximately $600 million in suspected fraudulent billing
• CMS Administrator Dr. Mehmet Oz later claimed the affected facilities had been billing roughly $750 million per year collectively
• As of April 18, 2026, Dr. Oz publicly stated that not one of the suspended facilities had contacted CMS to request reinstatement — his framing being that legitimate providers would have fought back

That last point is politically effective but legally meaningless. Silence is not a defense, and a rebuttal is not a phone call — it is a written, claim-by-claim documentation package with a hard 15-business-day deadline. Plenty of legitimate hospices in the 447 are scrambling to assemble one right now.

How We Got Here: The Timeline

This did not come out of nowhere. The April 2026 suspensions are the endpoint of a six-year escalation:

• 2019–2020: OIG publishes two-part report exposing systemic hospice quality and fraud issues; California criminal prosecutions begin
• 2021: Gov. Newsom signs SB 664, establishing a moratorium on new California hospice licenses
• 2023: CMS launches the Provisional Period of Enhanced Oversight (PPEO) in Arizona, California, Nevada, and Texas
• 2024: AB 177 extends the CA moratorium
• November 2025: PPEO expanded to Georgia and Ohio; CMS launches “Fraud Tax Project”
• January 12, 2026: Joint CMS/DOJ press conference announcing intensified hospice fraud enforcement
• February 3, 2026: House Oversight hearing “Common Schemes, Real Harm”
• March 2026: Trump executive order creates the Federal Task Force to Eliminate Fraud
• April 2, 2026: Feds charge 15 in a separate SoCal hospice fraud case
• April 9, 2026: CA AG Bonta announces the $267M LA hospice fraud ring takedown (21 charged) — same day the first wave of Qlarant suspension letters took effect
• April 14–17, 2026: Qlarant sends Notice of Suspension letters

Where the Authority Comes From

The legal mechanism CMS is using — suspension on a “credible allegation of fraud” (CAF) without prior notice — is not new. It was expanded under the Affordable Care Act of 2010 and codified in final rulemaking in 2011. Key features:

• 42 C.F.R. § 405.370(a) — defines “credible allegation of fraud” as an allegation from any source (hotline complaints, data mining, audits, civil false claims cases, law enforcement) that has “indicia of reliability”
• 42 C.F.R. § 405.371(a)(2) — authorizes suspension once a CAF exists
• 42 C.F.R. § 405.372(a)(4)(iii) — authorizes suspension without prior notice when notice would put additional Medicare funds at risk
• 42 C.F.R. § 405.372(b) — gives the provider 15 business days to submit a written rebuttal
• 42 C.F.R. § 405.375(c) — the response to your rebuttal is not an initial determination and is not appealable
• 180-day rule: CMS must re-evaluate the suspension every 180 days
• 18-month cap: Good cause to continue a suspension is presumed to end at 18 months unless OIG is actively pursuing administrative action

The combination of “no prior notice” and “rebuttal is not appealable” is what makes these letters so dangerous. You find out when the payments stop. You get 15 business days. And the process that decides whether the suspension stays in place is not an appeal — it is a single reviewer at Qlarant reading your documentation package.

What the Live Discharge Rate Allegation Actually Means

Most of the April 2026 letters cite a single headline statistic: the provider’s live discharge rate (including transfers) between January 1, 2025 and March 30, 2026 was materially higher than national patterns. Specific numbers named in letters seen so far run anywhere from the mid-50% range up to 100%. CMS has not published a hard threshold, but the audit window appears to cover any rate over roughly 40%.

For context, the national non-death hospice discharge rate is roughly 17–18%. A rate over 40% is more than twice the national average; the upper end of the band CMS is surfacing approaches six times the national average. CMS’s theory: an elevated live discharge rate suggests the hospice enrolled patients who did not actually meet the six-month terminal prognosis requirement under 42 C.F.R. § 418.22.

That is a theory, not a verdict. Legitimate reasons for elevated live discharge exist: long-stay patients who improve, transfers for reasons outside the hospice’s control, revocations, and cap-related discharges. But the burden is now on the provider to prove each flagged claim met every Medicare coverage requirement — claim by claim, not in aggregate.

We cover how to audit your own live discharge rate and what to do if it’s climbing into flag territory in a dedicated post: The Live Discharge Rate Trap.

What to Do First If You Got the Letter

1. Calendar the 15 business days from the date you received the letter. Qlarant will consider extensions on a case-by-case basis, but do not plan on one.
2. Pull every claim listed in the letter. The letters include a Claim Control Number (CCN) table — these are your example claims. You need the full chart for each one.
3. Assemble the required documentation for each example claim. At minimum: signed Election Statement, Election Statement Addendum (if requested), face-to-face documentation, initial 90-day Certification of Terminal Illness with physician narrative, all subsequent Recertifications with narratives, Plan of Care, and Interdisciplinary Team (IDT) meeting documentation.
4. Write the rebuttal claim-by-claim. General assertions that you’re a compliant provider will fail. The rebuttal has to show, claim by claim, that Medicare coverage and payment requirements were met.
5. Prepare for cash-flow impact immediately. Claims in process are also suspended. Our payroll survival guide covers what a suspension actually does to your cash position and the legitimate options for bridging the gap.
6. Do not send a rebuttal without legal and compliance review. Once submitted, you generally don’t get a second bite. The rebuttal is also not appealable.

The tactical detail — what documentation Qlarant reviewers are actually looking for and the common mistakes that sink rebuttals — is in our 15-Business-Day Rebuttal Playbook.

What to Do If You Didn’t Get a Letter (Yet)

The task force methodology that produced the 447 is not going away. AI-assisted billing review is being expanded, not retired. Any hospice in a PPEO state showing statistical outliers — elevated live discharge rate, unusual length-of-stay distributions, cap-adjacent billing, shared medical directors or addresses — is a candidate for the next sweep.

Three things every hospice should do this month:

• Pull your own live discharge rate for the last 15 months and compare to national benchmarks
• Audit a random sample of your own recent claims against the full documentation package Qlarant is requiring of the 447
• Know who your medical director’s other affiliations are — CMS does

Further Reading

• The 15-Business-Day Rebuttal Playbook for California Hospices
• The Live Discharge Rate Trap — How to Check Yours Before You’re Next
• Payments Frozen, Payroll Friday: A Cash-Flow Survival Playbook
• Alliance Urges CMS to Lean on PPEO Over Sweeping CRUSH Fraud Rules
• PPEO Is Expanding: What Georgia, Ohio, and Other States Need to Know
• 42 C.F.R. § 405.371 (eCFR)
• Duane Morris: U.S. Government Puts Fraud and Abuse Focus on Hospice Care in California

The Bottom Line

The April 2026 suspensions are the largest single-event enforcement action the hospice industry has ever seen. The federal task force behind them has explicitly said more are coming. If you got a letter, the 15-business-day clock is already running. If you didn’t, the methodology that produced the 447 is about to be pointed at everyone else in PPEO states.

Either way, the bar is the same: airtight claim-level documentation, statistical self-awareness, and a response plan you build before the letter arrives.